FDA RWD/RWE regulatory considerations in draft guidance highlight opportunities and challenges

Retrieved on: 2021-12-29 20:30:10

Tags for this article:

Click the tags to see associated articles and topics

FDA RWD/RWE regulatory considerations in draft guidance highlight opportunities and challenges. View article details on hiswai:

Excerpt

He further clarified that he “also want to assure people I'm not talking about willy-nilly analysis of data. I'm talking about well-planned ...

Article found on: www.jdsupra.com